FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113454545> ?p ?o ?g. }

• W2113454545 endingPage "1117" @default.
• W2113454545 startingPage "1109" @default.
• W2113454545 abstract "Anemia may increase the likelihood of achieving a sustained virological response (SVR) during pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) infection. To determine whether hemoglobin decline is associated with SVR, we retrospectively evaluated the CHARIOT study of 871 treatment-naïve HCV genotype 1 patients. Anemia (serum hemoglobin <100 g/L) occurred in 137 (16%) patients, of whom only 14 (10%) received erythropoietin. Hemoglobin decline >30g/L from baseline occurred in 76% of patients overall, including 526 patients who did not become anemic. Virological responses were higher in anemic patients compared with those who did not develop anemia (end of treatment, 80% versus 65%, P = 0.003; SVR, 61% versus 50%, P = 0.02); these differences remained significant when patients receiving erythropoietin were excluded from analysis. SVR was also higher in patients with hemoglobin decline >30 g/L compared with patients without a similar decline. In multiple logistic regression analyses with treatment group and baseline characteristics, the odds ratio for SVR was 1.97 (95% confidence interval, 1.08-3.62) for anemia and 2.17 (95% confidence interval, 1.31-3.62) for hemoglobin decline >30 g/L. Patients who first developed a hemoglobin decline >30 g/L during weeks 5-12 and 13-48 were more likely to achieve SVR than those who first developed such changes in weeks 0-4 or who never experienced them.Patients with HCV genotype 1 infection who develop anemia or experience a hemoglobin decline >30 g/L during weeks 5-48 of therapy achieve higher virological responses to pegylated interferon and ribavirin therapy that are unrelated to erythropoietin use." @default.
• W2113454545 created "2016-06-24" @default.
• W2113454545 creator A5007518376 @default.
• W2113454545 creator A5015694634 @default.
• W2113454545 creator A5020720433 @default.
• W2113454545 creator A5037354571 @default.
• W2113454545 creator A5052909853 @default.
• W2113454545 creator A5064552386 @default.
• W2113454545 creator A5066288177 @default.
• W2113454545 creator A5067004305 @default.
• W2113454545 creator A5080507561 @default.
• W2113454545 creator A5087176957 @default.
• W2113454545 creator A5079433869 @default.
• W2113454545 date "2011-04-01" @default.
• W2113454545 modified "2023-10-06" @default.
• W2113454545 title "Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1" @default.
• W2113454545 cites W1964264521 @default.
• W2113454545 cites W2003641083 @default.
• W2113454545 cites W2018432327 @default.
• W2113454545 cites W2051357230 @default.
• W2113454545 cites W2063285149 @default.
• W2113454545 cites W2088948861 @default.
• W2113454545 cites W2094174828 @default.
• W2113454545 cites W2099981943 @default.
• W2113454545 cites W2109235725 @default.
• W2113454545 cites W2130590119 @default.
• W2113454545 cites W2141777445 @default.
• W2113454545 cites W2312384004 @default.
• W2113454545 doi "https://doi.org/10.1002/hep.24180" @default.
• W2113454545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21480317" @default.
• W2113454545 hasPublicationYear "2011" @default.
• W2113454545 type Work @default.
• W2113454545 sameAs 2113454545 @default.
• W2113454545 citedByCount "38" @default.
• W2113454545 countsByYear W21134545452012 @default.
• W2113454545 countsByYear W21134545452013 @default.
• W2113454545 countsByYear W21134545452014 @default.
• W2113454545 countsByYear W21134545452015 @default.
• W2113454545 countsByYear W21134545452016 @default.
• W2113454545 countsByYear W21134545452018 @default.
• W2113454545 crossrefType "journal-article" @default.
• W2113454545 hasAuthorship W2113454545A5007518376 @default.
• W2113454545 hasAuthorship W2113454545A5015694634 @default.
• W2113454545 hasAuthorship W2113454545A5020720433 @default.
• W2113454545 hasAuthorship W2113454545A5037354571 @default.
• W2113454545 hasAuthorship W2113454545A5052909853 @default.
• W2113454545 hasAuthorship W2113454545A5064552386 @default.
• W2113454545 hasAuthorship W2113454545A5066288177 @default.
• W2113454545 hasAuthorship W2113454545A5067004305 @default.
• W2113454545 hasAuthorship W2113454545A5079433869 @default.
• W2113454545 hasAuthorship W2113454545A5080507561 @default.
• W2113454545 hasAuthorship W2113454545A5087176957 @default.
• W2113454545 hasBestOaLocation W21134545451 @default.
• W2113454545 hasConcept C126322002 @default.
• W2113454545 hasConcept C156957248 @default.
• W2113454545 hasConcept C203014093 @default.
• W2113454545 hasConcept C2522874641 @default.
• W2113454545 hasConcept C2776408679 @default.
• W2113454545 hasConcept C2776455275 @default.
• W2113454545 hasConcept C2776461080 @default.
• W2113454545 hasConcept C2778248108 @default.
• W2113454545 hasConcept C2778534260 @default.
• W2113454545 hasConcept C2778917026 @default.
• W2113454545 hasConcept C2780040827 @default.
• W2113454545 hasConcept C44249647 @default.
• W2113454545 hasConcept C71924100 @default.
• W2113454545 hasConcept C90924648 @default.
• W2113454545 hasConceptScore W2113454545C126322002 @default.
• W2113454545 hasConceptScore W2113454545C156957248 @default.
• W2113454545 hasConceptScore W2113454545C203014093 @default.
• W2113454545 hasConceptScore W2113454545C2522874641 @default.
• W2113454545 hasConceptScore W2113454545C2776408679 @default.
• W2113454545 hasConceptScore W2113454545C2776455275 @default.
• W2113454545 hasConceptScore W2113454545C2776461080 @default.
• W2113454545 hasConceptScore W2113454545C2778248108 @default.
• W2113454545 hasConceptScore W2113454545C2778534260 @default.
• W2113454545 hasConceptScore W2113454545C2778917026 @default.
• W2113454545 hasConceptScore W2113454545C2780040827 @default.
• W2113454545 hasConceptScore W2113454545C44249647 @default.
• W2113454545 hasConceptScore W2113454545C71924100 @default.
• W2113454545 hasConceptScore W2113454545C90924648 @default.
• W2113454545 hasIssue "4" @default.
• W2113454545 hasLocation W21134545451 @default.
• W2113454545 hasLocation W21134545452 @default.
• W2113454545 hasOpenAccess W2113454545 @default.
• W2113454545 hasPrimaryLocation W21134545451 @default.
• W2113454545 hasRelatedWork W2004479501 @default.
• W2113454545 hasRelatedWork W2009634266 @default.
• W2113454545 hasRelatedWork W2055190024 @default.
• W2113454545 hasRelatedWork W2067034737 @default.
• W2113454545 hasRelatedWork W2078888723 @default.
• W2113454545 hasRelatedWork W2108648362 @default.
• W2113454545 hasRelatedWork W2318824964 @default.
• W2113454545 hasRelatedWork W2321188506 @default.
• W2113454545 hasRelatedWork W2977427228 @default.
• W2113454545 hasRelatedWork W4229934245 @default.
• W2113454545 hasVolume "53" @default.
• W2113454545 isParatext "false" @default.

• next